Get the Stockscreener App
2.00
8.70%
0.16
Immuneering Corp Stock (IMRX) Forecast
The Immuneering Corp (IMRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.23, representing a +561.52% increase from the current price of $2.00. The highest analyst price target is $13.28, and the lowest is $13.18.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMRX Price Target
Average 6.6583
(+232.92% Upside)
Is Immuneering Corp (IMRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.32 | Neutral |
| STOCH(9,6) | 30.10 | Neutral |
| STOCHRSI(14) | 61.93 | Neutral |
| MACD(12,26) | -0.0589 | Sell |
| ADX(14) | 23.68 | Neutral |
| William %R | -41.46 | Neutral |
| CCI(14) | -10.05 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.8975
Buy
|
1.8879
Buy
|
| MA20 |
2.0108
Sell
|
1.9443
Buy
|
| MA50 |
2.0091
Sell
|
1.9765
Buy
|
| MA100 |
1.8632
Buy
|
1.9976
Buy
|
| MA200 |
1.8419
Buy
|
2.7298
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, IMRX could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on IMRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 51.32 indicates that IMRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.1 indicates that IMRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 61.93 indicates that IMRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.68 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -10.05 indicates that IMRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IMRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immuneering Corp financial reports and earnings history, Immuneering Corp (IMRX) stock could reach $44.58 by 2030, $66.49 by 2040 and $204.90 by 2050. See the projected annual prices until 2050 of the Immuneering Corp stock below:
- Immuneering Corp (IMRX) is expected to reach an average price of $17.65 in 2035, with a high prediction of $19.41 and a low estimate of $19.87. This indicates an $782.44% rise from the last recorded price of $2.00.
- Immuneering Corp (IMRX) stock is projected to chart a bullish course in 2040, with an average price target of $60.90, representing an $2,945% surge from its current level. The forecast ranges from a conservative $61.96 to a sky-high $66.49.
- Our analysts predict Immuneering Corp (IMRX) to jump 6,235% by 2045, soaring from $127.42 to an average price of $126.69, potentially reaching $129.73. While $127.42 is the low estimate, the potential upside is significant.
- Immuneering Corp (IMRX) stock is expected to climb by 2050, reaching an average of $206.45, a $10,222% jump from its current level. However, a wide range of estimates exists, with high and low targets of $204.90 and $207.20, respectively, highlighting the market's uncertainty.
Immuneering Corp Stock (IMRX) Year by Year Forecast
Immuneering Corp Stock (IMRX) Price Forecast for 2025
Immuneering Corp Stock (IMRX) is expected to reach an average price of $6.6583 in 2025, with a high prediction of $13.28 and a low estimate of $0.0344. This indicates an +232.92% rise from the last recorded price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.71 | $13.18 | $13.28 | +535.43% |
| February, 2025 | $10.60 | $10.63 | $10.26 | +429.84% |
| March, 2025 | $10.50 | $10.71 | $9.9889 | +424.75% |
| April, 2025 | $5.5354 | $5.9554 | $10.03 | +176.77% |
| May, 2025 | $2.2237 | $3.2887 | $1.3174 | +11.18% |
| June, 2025 | $7.0319 | $1.8877 | $4.0919 | +251.60% |
| July, 2025 | $8.6823 | $8.0381 | $7.4823 | +334.11% |
| August, 2025 | $9.3305 | $9.3785 | $8.5765 | +366.53% |
| September, 2025 | $8.4888 | $8.5488 | $8.5447 | +324.44% |
| October, 2025 | $7.0491 | $7.2391 | $8.2634 | +252.46% |
| November, 2025 | $0.9774 | $4.0224 | $6.0612 | -51.13% |
| December, 2025 | $0.3723 | $0.0344 | $3.5344 | -81.39% |
Immuneering Corp Stock (IMRX) Price Forecast for 2026
The predicted value for Immuneering Corp (IMRX) in 2026 is set at an average of $2.3931. Estimates vary from a peak of $4.7648 to a trough of $0.0214, indicating an +19.66% surge from the present price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.531 | $2.5939 | $2.1218 | +76.55% |
| February, 2026 | $1.7858 | $0.6242 | $2.068 | -10.71% |
| March, 2026 | $1.0675 | $0.1875 | $2.6437 | -46.63% |
| April, 2026 | $2.0572 | $0.3964 | $2.7492 | +2.86% |
| May, 2026 | $1.4989 | $0.5151 | $2.453 | -25.06% |
| June, 2026 | $0.7706 | $0.2527 | $2.0906 | -61.47% |
| July, 2026 | $0.8603 | $0.0214 | $1.1386 | -56.99% |
| August, 2026 | $2.122 | $0.1318 | $2.407 | +6.10% |
| September, 2026 | $2.1617 | $0.69 | $3.7558 | +8.08% |
| October, 2026 | $1.6634 | $1.3134 | $3.2296 | -16.83% |
| November, 2026 | $2.9552 | $1.4372 | $3.1252 | +47.76% |
| December, 2026 | $3.6448 | $2.4281 | $4.7648 | +82.24% |
Immuneering Corp Stock (IMRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immuneering Corp (IMRX) is $16.92, with a high forecast of $33.68 and a low forecast of $0.1534. This indicates an +745.84% increase from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1334 | $0.1534 | $3.8828 | -93.33% |
| February, 2027 | $0.3117 | $0.2455 | $0.1517 | -84.41% |
| March, 2027 | $26.40 | $0.2038 | $21.69 | +1,220% |
| April, 2027 | $28.42 | $25.31 | $24.06 | +1,321% |
| May, 2027 | $33.41 | $30.36 | $30.85 | +1,570% |
| June, 2027 | $34.08 | $33.33 | $33.39 | +1,604% |
| July, 2027 | $33.74 | $34.35 | $33.68 | +1,587% |
| August, 2027 | $32.49 | $32.63 | $32.80 | +1,524% |
| September, 2027 | $33.05 | $33.28 | $32.60 | +1,552% |
| October, 2027 | $32.15 | $32.82 | $32.81 | +1,507% |
| November, 2027 | $30.30 | $31.41 | $31.43 | +1,415% |
| December, 2027 | $27.71 | $27.90 | $30.02 | +1,286% |
Immuneering Corp Stock (IMRX) Price Forecast for 2028
In 2028, Immuneering Corp (IMRX) is projected to reach an average price of $18.50, with a high projection of $26.96 and a low estimate of $10.05. This indicates an +825.16% rise from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $27.02 | $27.23 | $26.96 | +1,251% |
| February, 2028 | $19.59 | $23.30 | $26.40 | +879.33% |
| March, 2028 | $17.42 | $18.48 | $18.19 | +770.87% |
| April, 2028 | $21.63 | $16.79 | $18.69 | +981.69% |
| May, 2028 | $22.54 | $22.20 | $21.41 | +1,027% |
| June, 2028 | $22.60 | $22.65 | $22.14 | +1,030% |
| July, 2028 | $21.17 | $21.23 | $21.52 | +958.38% |
| August, 2028 | $18.99 | $19.18 | $20.79 | +849.41% |
| September, 2028 | $12.32 | $15.37 | $17.85 | +516.24% |
| October, 2028 | $10.08 | $10.72 | $11.71 | +404.06% |
| November, 2028 | $13.55 | $11.40 | $12.43 | +577.35% |
| December, 2028 | $7.6385 | $10.05 | $11.94 | +281.92% |
Immuneering Corp Stock (IMRX) Price Forecast for 2029
The 2029 price forecast for Immuneering Corp Stock (IMRX) is $3.8865 on average, with a high prediction of $7.7268 and a low estimate of $0.0462. This represents an +94.32% increase from the previous price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.2092 | $8.2882 | $7.7268 | +260.46% |
| February, 2029 | $6.0357 | $6.6374 | $6.2334 | +201.78% |
| March, 2029 | $6.0022 | $6.1722 | $5.6472 | +200.11% |
| April, 2029 | $6.1388 | $6.4388 | $6.0905 | +206.94% |
| May, 2029 | $5.3094 | $6.7829 | $6.4812 | +165.47% |
| June, 2029 | $3.456 | $5.8137 | $5.7718 | +72.80% |
| July, 2029 | $1.9725 | $3.0183 | $2.8601 | -1.38% |
| August, 2029 | $2.5831 | $2.509 | $1.919 | +29.16% |
| September, 2029 | $0.6997 | $1.8791 | $1.7173 | -65.02% |
| October, 2029 | $0.7297 | $0.0462 | $1.8497 | -63.52% |
| November, 2029 | $2.4569 | $2.4769 | $1.9986 | +22.84% |
| December, 2029 | $2.0434 | $2.0834 | $2.041 | +2.17% |
Immuneering Corp Stock (IMRX) Price Forecast for 2030
Immuneering Corp Stock (IMRX) is expected to reach an average price of $28.14 in 2030, with a high forecast of $54.50 and a low forecast of $1.7875. This signifies an +1,307% surge from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $49.29 | $1.7875 | $44.58 | +2,364% |
| February, 2030 | $50.71 | $47.90 | $46.35 | +2,436% |
| March, 2030 | $55.11 | $52.51 | $52.55 | +2,655% |
| April, 2030 | $55.00 | $54.72 | $54.20 | +2,650% |
| May, 2030 | $54.11 | $54.84 | $54.50 | +2,606% |
| June, 2030 | $52.27 | $52.41 | $52.88 | +2,513% |
| July, 2030 | $52.09 | $52.82 | $51.90 | +2,504% |
| August, 2030 | $50.59 | $51.42 | $51.55 | +2,430% |
| September, 2030 | $48.16 | $49.26 | $49.59 | +2,308% |
| October, 2030 | $44.83 | $45.16 | $47.73 | +2,142% |
| November, 2030 | $43.55 | $43.76 | $43.93 | +2,077% |
| December, 2030 | $35.52 | $39.23 | $42.78 | +1,676% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):